| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 异龙胆黄素; Isogentisin | CFN70382 | 491-64-5 | C14H10O5 = 258.2 | 5mg | QQ客服：1413575084 |
| 去甲当药醇苷; Norswertianolin | CFN91770 | 54954-12-0 | C19H18O11 = 422.34 | 5mg | QQ客服：1457312923 |
| Neolancerin; Neolancerin | CFN91802 | 117221-65-5 | C19H18O10 = 406.34 | 10mg | QQ客服：3257982914 |
| 3'-O-当归酰基亥茅酚; 3'-O-Angeloylhamaudol | CFN91666 | 84272-84-4 | C20H22O6 = 358.39 | 5mg | QQ客服：2056216494 |
| Diphlorethohydroxycarmalol; Diphlorethohydroxycarmalol | CFN91654 | 138529-04-1 | C24H16O13 = 512.4 | 5mg | QQ客服：215959384 |
| 锰黄原酮IV; Mangostanaxanthone IV | CFN91525 | 2182593-73-1 | C24H26O7 = 426.5 | 5mg | QQ客服：2056216494 |
| 藤黄酮B; Garcixanthones B | CFN91524 | 2522597-99-3 | C23H24O5 = 380.4 | 5mg | QQ客服：1413575084 |
| 11-羟基-1-异倒棯子素; 11-hydroxy-1-isomangostin | CFN91523 | 164365-71-3 | C24H26O7 = 426.5 | 5mg | QQ客服：2056216494 |
| 西伯利亚远志呫吨酮A; Sibiricaxanthone A | CFN94507 | 241125-76-8 | C24H26O14 = 538.45 | 5mg | QQ客服：1413575084 |
| Mangostenol; Mangostenol | CFN95747 | 437711-43-8 | C24H26O7 = 426.5 | 5mg | QQ客服：2056216494 |
| Mangostanin; Mangostanin | CFN95797 | 463342-39-4 | C24H26O7 = 426.5 | 5mg | QQ客服：3257982914 |
| Mangostenone F; Mangostenone F | CFN95798 | 1242438-70-5 | C24H24O6 = 408.5 | 5mg | QQ客服：1457312923 |
| Mangostenol peroxide; Mangostenol peroxide | CFN95799 | N/A | C24H26O8 = 442.5 | 5mg | QQ客服：215959384 |
| Garcinexanthone C; Garcinexanthone C | CFN95802 | 1107620-69-8 | C18H16O6 = 328.3 | 5mg | QQ客服：2159513211 |
| 6-甲氧基-二吡喃山酮; 6-Methoxy-bispyranoxanthone | CFN91419 | 115713-10-5 | C24H26O6 = 410.5 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)